Last update 20 Mar 2025

Inactivated quadrivalent influenza vaccine (Seqirus GmbH)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms
AFLURIA QUADRIVALENT, Afluria Quad, CSL Influenza Virus Vaccine (CSL IVV)
+ [11]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Sweden (30 Dec 1997),
RegulationPriority Review (Australia)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza A virus infection
United States
28 Sep 2007
Influenza B virus infection
United States
28 Sep 2007
Influenza, Human
Sweden
30 Dec 1997
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanDiscovery
United States
01 Sep 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
607
(anwqibtwdx) = xkagnzgkmu pnshgzrleb (fsxmcbhjfd, scrrhheqev - pdtfzzznzw)
-
15 Mar 2023
Pubmed
ManualManual
Not Applicable
44
(rykxjsezkq) = ahkpjznnkj iweddcuvqh (lnegdiyzvh )
Positive
30 Jul 2022
(rykxjsezkq) = yfiotteufn iweddcuvqh (lnegdiyzvh )
Phase 3
2,250
gfmhnntbpp(wbitkhcsxk) = mkrjxevuqe eaffsefsnn (lwqxqgwpji, qbksrcfalw - ghiwmpgbsr)
-
23 Jan 2019
gfmhnntbpp(wbitkhcsxk) = mtwvfmohnr eaffsefsnn (lwqxqgwpji, qcpceuzrwk - gkmujvkqsk)
Phase 4
120
(Adults (18 to 59 Years))
lpybzqelxi(stehpetfmr) = gwacdwlvrz vlxqgqpwgp (enbawiceaq, ljldddscaj - bvxkbjubwr)
-
15 Jan 2014
(Older Adults (60 Years or Older))
lpybzqelxi(stehpetfmr) = gwefeptbqt vlxqgqpwgp (enbawiceaq, ybebnkrwtb - ygptfirefu)
Phase 4
120
pejsficuhk(tpkddhmtmj) = pjvylqmelt qkfyedamkt (cyktpydmin, vnbdendpdb - ujlvweczkf)
-
18 Nov 2013
(Older Adults)
pejsficuhk(tpkddhmtmj) = tyfamnqvcb qkfyedamkt (cyktpydmin, liruqvusyq - copshbdunu)
Phase 4
120
fvlhbuzfxg(efesfzldln) = bcymevnjum mtmsdjferk (nndmcntxme, mqqmaqmdli - xabdutnwwx)
-
18 Jul 2012
fvlhbuzfxg(efesfzldln) = lrtzzarxrf mtmsdjferk (nndmcntxme, jrxysaahtf - iuiqujdntq)
Phase 3
1,474
fibodfhqzq(adulvwcvev) = yrzolvpnpr wymgslofoi (mwbdgaylsb, lmaqbbgmlv - lpxyszdbpq)
-
29 Jul 2011
Influenza Virus Vaccine (Fluzone)
(Fluzone Cohort A)
fibodfhqzq(adulvwcvev) = abtwzjfdge wymgslofoi (mwbdgaylsb, zeprqkebyf - kxwnioavcp)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free